|
Volumn 346, Issue , 2013, Pages
|
Drug companies should release data from all trials of licensed drugs, say MPs.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACCESS TO INFORMATION;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG INDUSTRY;
ETHICS;
GOVERNMENT REGULATION;
LEGAL ASPECT;
NOTE;
UNITED KINGDOM;
ACCESS TO INFORMATION;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
DRUG INDUSTRY;
GOVERNMENT REGULATION;
GREAT BRITAIN;
|
EID: 84874485114
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.f321 Document Type: Note |
Times cited : (3)
|
References (0)
|